Mechanism of Action · N0000000103
Reverse Transcriptase Inhibitors
Pharmacological class containing 14 drugs per the Mechanism of Action taxonomy.
Drugs in this class (14)
Need clinical context — common uses, side effects, or interactions for this class?
Ask GoDavaii AI about Reverse Transcriptase InhibitorsCommon questions about Reverse Transcriptase Inhibitors
What is the Reverse Transcriptase Inhibitors drug class?
Reverse Transcriptase Inhibitors is a pharmacological class in the Mechanism of Action taxonomy, classification code N0000000103. It groups 14 drugs that share a similar mechanism of action, chemical structure, or therapeutic use.
Which drugs are part of the Reverse Transcriptase Inhibitors class?
Notable drugs in the Reverse Transcriptase Inhibitors class include rilpivirine, zidovudine, tenofovir anhydrous, entecavir anhydrous, adefovir, and 9 more. The complete member list is shown above on this page; tap any drug name to see its full Indian-context information sheet.
What does Mechanism of Action mean?
Mechanism of Action is one of the standard taxonomies used by the NIH National Library of Medicine to organise drugs. Different taxonomies group drugs by different criteria - some by chemical structure, some by what they do in the body, some by therapeutic intent. Together these classifications make medical research, prescribing and education more consistent across the world.
Where can I get plain-language clinical context for the Reverse Transcriptase Inhibitors class?
For plain-language clinical context - common uses, side effects, drug interactions and what the class means for an Indian patient - ask GoDavaii's Health AI. It works in 22+ Indian languages, is free and needs no signup. Tap "Ask GoDavaii AI about Reverse Transcriptase Inhibitors" above.
Source: NIH RxClass — National Library of Medicine, public domain. Class taxonomy: Mechanism of Action. View on RxClass ↗